These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease. Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770 [TBL] [Abstract][Full Text] [Related]
3. Reactive macrophages increase oxidative stress and alpha-synuclein nitration during death of dopaminergic neuronal cells in co-culture: relevance to Parkinson's disease. Shavali S; Combs CK; Ebadi M Neurochem Res; 2006 Jan; 31(1):85-94. PubMed ID: 16475001 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
5. Magnesium Lithospermate B Suppresses Lipopolysaccharide-Induced Neuroinflammation in BV2 Microglial Cells and Attenuates Neurodegeneration in Lipopolysaccharide-Injected Mice. Tai Y; Qiu Y; Bao Z J Mol Neurosci; 2018 Jan; 64(1):80-92. PubMed ID: 29196883 [TBL] [Abstract][Full Text] [Related]
6. Hyperoside inhibits lipopolysaccharide-induced inflammatory responses in microglial cells via p38 and NFκB pathways. Fan HH; Zhu LB; Li T; Zhu H; Wang YN; Ren XL; Hu BL; Huang CP; Zhu JH; Zhang X Int Immunopharmacol; 2017 Sep; 50():14-21. PubMed ID: 28622577 [TBL] [Abstract][Full Text] [Related]
8. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models. Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602 [TBL] [Abstract][Full Text] [Related]
9. Acetyl-L-Carnitine via Upegulating Dopamine D1 Receptor and Attenuating Microglial Activation Prevents Neuronal Loss and Improves Memory Functions in Parkinsonian Rats. Singh S; Mishra A; Srivastava N; Shukla R; Shukla S Mol Neurobiol; 2018 Jan; 55(1):583-602. PubMed ID: 27975173 [TBL] [Abstract][Full Text] [Related]
10. Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease. Bao LH; Zhang YN; Zhang JN; Gu L; Yang HM; Huang YY; Xia N; Zhang H J Neuroinflammation; 2018 May; 15(1):131. PubMed ID: 29720230 [TBL] [Abstract][Full Text] [Related]
11. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats. Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220 [TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase. Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817 [TBL] [Abstract][Full Text] [Related]
13. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003 [TBL] [Abstract][Full Text] [Related]
14. Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease. Son HJ; Han SH; Lee JA; Shin EJ; Hwang O Free Radic Res; 2017 Jun; 51(6):633-645. PubMed ID: 28770670 [TBL] [Abstract][Full Text] [Related]
15. Role of microgliosis, oxidative stress and associated neuroinflammation in the pathogenesis of Parkinson's disease: The therapeutic role of Nrf2 activators. Jayaram S; Krishnamurthy PT Neurochem Int; 2021 May; 145():105014. PubMed ID: 33689805 [TBL] [Abstract][Full Text] [Related]
16. Histamine induces microglia activation and dopaminergic neuronal toxicity via H1 receptor activation. Rocha SM; Saraiva T; Cristóvão AC; Ferreira R; Santos T; Esteves M; Saraiva C; Je G; Cortes L; Valero J; Alves G; Klibanov A; Kim YS; Bernardino L J Neuroinflammation; 2016 Jun; 13(1):137. PubMed ID: 27260166 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450 [TBL] [Abstract][Full Text] [Related]
18. Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide. Villa V; Thellung S; Bajetto A; Gatta E; Robello M; Novelli F; Tasso B; Tonelli M; Florio T Pharmacol Res; 2016 Nov; 113(Pt A):500-514. PubMed ID: 27667770 [TBL] [Abstract][Full Text] [Related]
19. Transduced PEP-1-PON1 proteins regulate microglial activation and dopaminergic neuronal death in a Parkinson's disease model. Kim MJ; Park M; Kim DW; Shin MJ; Son O; Jo HS; Yeo HJ; Cho SB; Park JH; Lee CH; Kim DS; Kwon OS; Kim J; Han KH; Park J; Eum WS; Choi SY Biomaterials; 2015 Sep; 64():45-56. PubMed ID: 26117230 [TBL] [Abstract][Full Text] [Related]
20. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease. Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]